sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma

BACKGROUND: Novel chimeric antigen receptor T-cells (CAR-T) target the B-cell maturation antigen (BCMA) expressed on multiple myeloma cells. Assays monitoring CAR-T cell expansion and treatment response are being implemented in clinical routine. METHODS: Plasma levels of soluble BCMA (sBCMA) and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Seipel, Katja, Porret, Naomi, Wiedemann, Gertrud, Jeker, Barbara, Bacher, Vera Ulrike, Pabst, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164019/
https://www.ncbi.nlm.nih.gov/pubmed/35723356
http://dx.doi.org/10.3390/cimb44040098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164019/
https://www.ncbi.nlm.nih.gov/pubmed/35723356
http://dx.doi.org/10.3390/cimb44040098

Ejemplares similares